The Food and Drug Administration approved a once-daily HIV pill from Gilead that could help simplify care for some patients, the company announced Thursday. The drug, marketed…

Build your stock portfolio and get lifetime investing support from Sterling Stock Picker for only $55. Read More: Simplify Investing With Personalized Stock Recommendations From This…

The burden of complianceOne of the primary issues raised in the report is the excessive burden placed on companies to demonstrate compliance.The ‘Do No Significant Harm’…